Javascript must be enabled to continue!
PLK1 promotes the mitotic surveillance pathway by controlling cytosolic 53BP1 availability
View through CrossRef
Abstract
53BP1 acts at the crossroads between DNA repair and p53‐mediated stress response. With its interactors p53 and USP28, it is part of the mitotic surveillance (or mitotic stopwatch) pathway (MSP), a sensor that monitors the duration of cell division, promoting p53‐dependent cell cycle arrest when a critical time threshold is surpassed. Here, we show that Polo‐like kinase 1 (PLK1) activity is essential for the time‐dependent release of 53BP1 from kinetochores. PLK1 inhibition, which leads to 53BP1 persistence at kinetochores, prevents cytosolic 53BP1 association with p53 and results in a blunted MSP. Strikingly, the identification of CENP‐F as the kinetochore docking partner of 53BP1 enabled us to show that measurement of mitotic timing by the MSP does not take place at kinetochores, as perturbing CENP‐F‐53BP1 binding had no measurable impact on the MSP. Taken together, we propose that PLK1 supports the MSP by generating a cytosolic pool of 53BP1 and that an unknown cytosolic mechanism enables the measurement of mitotic duration.
Springer Science and Business Media LLC
Title: PLK1 promotes the mitotic surveillance pathway by controlling cytosolic 53BP1 availability
Description:
Abstract
53BP1 acts at the crossroads between DNA repair and p53‐mediated stress response.
With its interactors p53 and USP28, it is part of the mitotic surveillance (or mitotic stopwatch) pathway (MSP), a sensor that monitors the duration of cell division, promoting p53‐dependent cell cycle arrest when a critical time threshold is surpassed.
Here, we show that Polo‐like kinase 1 (PLK1) activity is essential for the time‐dependent release of 53BP1 from kinetochores.
PLK1 inhibition, which leads to 53BP1 persistence at kinetochores, prevents cytosolic 53BP1 association with p53 and results in a blunted MSP.
Strikingly, the identification of CENP‐F as the kinetochore docking partner of 53BP1 enabled us to show that measurement of mitotic timing by the MSP does not take place at kinetochores, as perturbing CENP‐F‐53BP1 binding had no measurable impact on the MSP.
Taken together, we propose that PLK1 supports the MSP by generating a cytosolic pool of 53BP1 and that an unknown cytosolic mechanism enables the measurement of mitotic duration.
Related Results
Identification of PLK1 as a proviral factor for the hepatitis B virus replication : A possible target for antiviral and anticancerous drug development
Identification of PLK1 as a proviral factor for the hepatitis B virus replication : A possible target for antiviral and anticancerous drug development
Développement et utilisation d'ARN interférents dirigés contre PLK1 dans le cadre d'une infection chronique par le virus de l'hépatite B
Dans les régions de fortes ...
Abstract 5172: Mechanistic insights into PLK1 target inhibition in ovarian cancer: Functional suppression and PROTAC-based therapeutic agents
Abstract 5172: Mechanistic insights into PLK1 target inhibition in ovarian cancer: Functional suppression and PROTAC-based therapeutic agents
Abstract
OBJECTIVE:
This study aimed to identify the oncogenic role of PLK1(Polo-like kinase 1) in ovarian cancer and eva...
UBAP2L-dependent coupling of PLK1 localization and stability during mitosis
UBAP2L-dependent coupling of PLK1 localization and stability during mitosis
Abstract
PLK1 is an important regulator of mitosis whose protein levels and activity fluctuate during the cell cycle. PLK1 dynamically localizes to various mitotic ...
The mitotic surveillance pathway requires PLK1-dependent 53BP1 displacement from kinetochores
The mitotic surveillance pathway requires PLK1-dependent 53BP1 displacement from kinetochores
Abstract
53BP1 acts at the crossroads between DNA repair and p53-mediated stress response. With its interactor USP28, it is part of the mitotic surveillance pathway...
Abstract 5777: Functional role of PLK1 in colorectal cancer progression and its potential to chemoresistance
Abstract 5777: Functional role of PLK1 in colorectal cancer progression and its potential to chemoresistance
Abstract
OBJECTIVE:
Colorectal cancer is a cancer with high prevalence and mortality rates worldwide, treated with surger...
Abstract 1133: Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state
Abstract 1133: Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state
Abstract
One outcome of activation of the PI3K pathway is increased aerobic glycolysis, but the upstream signaling events that regulate the PI3K pathway, thus the Wa...
Abstract 1720: 53BP1 regulates heterochromatin through liquid-liquid phase separation (LLPS)
Abstract 1720: 53BP1 regulates heterochromatin through liquid-liquid phase separation (LLPS)
Abstract
As compacted DNA, heterochromatin represses abnormal gene expression by inhibiting DNA transcription and maintains genome integrity by protecting aberrant c...
Abstract 3459: Dual targeting of BTK and PLK1 causes lethal synergistic effects in mantle cell lymphoma
Abstract 3459: Dual targeting of BTK and PLK1 causes lethal synergistic effects in mantle cell lymphoma
Abstract
Mantle cell lymphoma (MCL) is an incurable, aggressive B cell malignancy. Ibrutinib, an oral irreversible Bruton's tyrosine (BTK) inhibitor, was FDA-approve...

